# Efficacy of Naltrexone HCl/Bupropion HCl Extended Release Versus Placebo for Treatment of Weight Regain in Participants Post Bariatric Surgery

> **NCT02616315** · PHASE4 · WITHDRAWN · sponsor: **Takeda**

## Conditions studied

- Weight Regain Post Bariatric Surgery

## Interventions

- **DRUG:** Naltrexone HCl/Bupropion HCl Placebo
- **DRUG:** Naltrexone HCl/Bupropion HCl

## Key facts

- **NCT ID:** NCT02616315
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-02
- **Primary completion:** 2017-10
- **Final completion:** 2017-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02616315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02616315, "Efficacy of Naltrexone HCl/Bupropion HCl Extended Release Versus Placebo for Treatment of Weight Regain in Participants Post Bariatric Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02616315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*